SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: E_K_S who wrote (68522)10/21/2021 7:21:10 PM
From: Rarebird  Read Replies (3) of 78774
 
ABBV is a $145 stock based on my technical indicators. There was a lot of damage done to the chart, but nothing that can't be repaired over the next 12 months. Fundamentally, the news concerning the heart problems associated with the drug was an orchestrated endeavor to push the stock lower and it was successful. It is amazing sometimes to see what the Street will hype to achieve its goals.

Took a long position in ABBV today. $105.50 is strong support. Below $102 head for the hills.

For me, it is all about Risk vs Reward.

The patient, ABBV, is recovering nicely. I have a very healthy prognosis, a Hallmark movie ending for the stock over the next 12 months.

Sometimes the light does emerge from the Dark .
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext